| NCT ID | Title | Status | Phases | Start Date | Completion Date | Primary Completion Date |
|---|---|---|---|---|---|---|
| NCT06656351 | B-FREE Chronic Babesiosis Study | NOT_YET_RECRUITING | PHASE2 | 2025-11 | 2027-09 | 2027-02 |
| NCT06207370 | Oral Tafenoquine Plus Standard of Care Versus Placebo Plus Standard of Care for Babesiosis | RECRUITING | PHASE2 | 2024-06-17 | 2025-07-01 | 2025-03-01 |
| NCT04533347 | Tafenoquine in Patients With Mild to Moderate COVID-19 | COMPLETED | PHASE2 | 2021-02-19 | 2022-06-30 | 2022-06-30 |
| NCT03320174 | Long-Term Safety Study of Tafenoquine | COMPLETED | PHASE2 | 2017-10-05 | 2021-07-13 | 2021-07-13 |